Hepatitis B Trial, Recruiting NCT07491848 Sponsor: Research Center of Periodontal-Systemic Interactions Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT07491848
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are able to give their informed consent to participate
  • People in the Hepatitis B+D groups: those who have been confirmed to have both a hepatitis B and hepatitis D infection at the same time
  • People in the Bulevirtide group: those who are currently being treated with a medication called bulevirtide, as prescribed by their doctor
  • People in the No Bulevirtide group: those who are not currently being treated with bulevirtide
  • People in the Healthy Control group: adults who are in general good health and do not have hepatitis B or D infection
  • People who are willing to have a mouth and gum examination, provide saliva and gum fluid samples, and have photos taken of their mouth

Who may not be able to join:

  • People who have other long-term health conditions that could affect gum health, such as uncontrolled diabetes or autoimmune diseases
  • People who are currently taking part in another experimental treatment that may affect inflammation in the mouth or body
  • People who are pregnant or breastfeeding
  • People who are unable or unwilling to give their informed consent to participate
  • People who have had mouth or gum surgery in the last 6 months that could affect the study measurements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0040745538483

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Research Center of Periodontal-Systemic Interactions
Registry
ClinicalTrials.gov
Start date
15 February 2026
Est. completion
15 February 2027

Where this trial is recruiting

🇷🇴 Romania

Primary endpoints

Salivary inflammatory biomarker levels; Gingival crevicular fluid inflammatory biomarker levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov